A molecular signature of proteinuria in glomerulonephritis

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Reich, Heather N ^a,b   Tritchler, David ^a,c   Cattran, Daniel C ^a,b   Herzenberg, Andrew M ^a   Eichinger, Felix ^d   Boucherot, Anissa ^d   Henger, Anna ^d   Berthier, Celine C ^d   Nair, Viji ^d   Cohen, Clemens D ^e   Scholey, James W ^a,b   Kretzler, Matthias ^d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Toronto Glomerulonephritis Registry   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MESSENGER RNA; ALBUMINOID;

ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IN VITRO STUDY; KIDNEY BIOPSY; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEINURIA; REGULATORY SEQUENCE; BIOPSY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; KIDNEY; PATHOLOGY;

ALBUMINS; BIOPSY; GENE EXPRESSION PROFILING; GLOMERULONEPHRITIS; HUMANS; KIDNEY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINURIA;

EID: 78149424699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013451     Document Type: Article

References (87)

1. Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 36: 383-388.
2. Row PG, Cameron JS, Turner DR, Evans DJ, White RH, et al. (1975) Membranous nephropathy long-term follow-up and association with neoplasia. Ateneo Parmense Acta Biomed 46: 433-454.
3. Cameron JS (1990) Proteinuria and progression in human glomerular diseases. Am J Nephrol 10 Suppl 1: 81-87.
4. Gall MA, Nielsen FS, Smidt UM, Parving HH (1993) The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36: 1071-1078.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensinconverting- enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456-1462.
6. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, et al. (1995) Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int 47: 1781-1789.
7. Christensen PK, Rossing P, Nielsen FS, Parving HH (1999) Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy. Diabet Med 16: 388-394.
8. Philibert D, Cattran D (2008) Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price? Nat Clin Pract Nephrol 4: 550-559.
9. D'Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727.
10. D'Amico G (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Seminars in Nephrology 24: 179-196.
11. Bartosik LP, Lajoie G, Sugar L, Cattran DC (2001) Predicting progression in IgA nephropathy. Am J Kidney Dis 38: 728-735.
12. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H (1983) IgA nephropathy: prognostic significance of proteinuria and histological alterations. Nephron 34: 146-153.
13. Ibels LS, Gyory AZ (1994) IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 73: 79-102.
14. Radford MG, Jr., Donadio JV, Jr., Bergstralh EJ, Grande JP (1997) Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8: 199-207.
15. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. ''Gruppo Italiano di Studi Epidemiologici in Nefrologia'' (GISEN). Kidney Int 53: 1209-1216.
16. Li PK, Ho KK, Szeto CC, Yu L, Lai FM (2002) Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant 17: 64-69.
17. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM (2002) Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 17: 1197-1203.
18. Reich HN, Troyanov S, Scholey JW, Cattran DC (2007) Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18: 3177-3183.
19. Bohle A, Mackensen-Haen S, von Gise H (1987) Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol 7: 421-433.
20. Nath KA (1992) Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17.
21. Gilbert RE, Cooper ME (1999) The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56: 1627-1637.
22. Kriz W, Hartmann I, Hosser H, Hahnel B, Kranzlin B, et al. (2001) Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J Am Soc Nephrol 12: 496-506.
23. Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456.
24. Eddy AA (2004) Proteinuria and interstitial injury. Nephrol Dial Transplant 19: 277-281.
25. Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, et al. (2002) Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int 61: 2066-2077.
26. Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, et al. (2000) Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 36: 1226-1241.
27. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, et al. (1995) Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 26: 934-941.
28. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, et al. (1998) Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53: 1608-1615.
29. Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, et al. (2005) Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol 16: 1266-1278.
30. Tang S, Leung JC, Abe K, Chan KW, Chan LY, et al. (2003) Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111: 515-527.
31. Diwakar R, Pearson AL, Colville-Nash P, Brunskill NJ, Dockrell ME (2007) The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells. Am J Physiol Renal Physiol 292: F1464-F1470.
32. Theilig F, Kriz W, Jerichow T, Schrade P, Hahnel B, et al. (2007) Abrogation of Protein Uptake through Megalin-Deficient Proximal Tubules Does Not Safeguard against Tubulointerstitial Injury. J Am Soc Nephrol 18: 1824-1834.
33. Meyer TW (2003) Tubular injury in glomerular disease. Kidney Int 63: 774-787.
34. Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, et al. (2009) Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 174: 2073-2085.
35. Zoja C, Benigni A, Remuzzi G (2004) Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 13: 31-37.
36. Cohen CD, Frach K, Schlondorff D, Kretzler M (2002) Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 61: 133-140.
37. Kretzler M, Cohen CD, Doran P, Henger A, Madden S, et al. (2002) Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 13: 1961-1972.
38. Striker LJ, Striker GE (2003) Windows on renal biopsy interpretation: does mRNA analysis represent a new gold standard? J Am Soc Nephrol 14: 1096-1098.
39. Waga I, Yamamoto J, Sasai H, Munger WE, Hogan SL, et al. (2003) Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy. Kidney Int 64: 1253-1264.
40. Schmid H, Cohen CD, Henger A, Schlondorff D, Kretzler M (2004) Gene expression analysis in renal biopsies. Nephrol Dial Transplant 19: 1347-1351.
41. Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, et al. (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113: 1722-1733.
42. Porubsky S, Schmid H, Bonrouhi M, Kretzler M, Malle E, et al. (2004) Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol 164: 2175-2187.
43. Henger A, Kretzler M, Doran P, Bonrouhi M, Schmid H, et al. (2004) Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 65: 904-917.
44. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, et al. (2006) Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003.
45. Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, et al. (2008) The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant 23: 2247-2253.
46. Eddy AA, Giachelli CM (1995) Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546-1557.
47. Eddy AA, Fogo AB (2006) Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 17: 2999-3012.
48. Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, et al. (2000) Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int 58: 1219-1227.
49. Oda T, Jung YO, Kim HS, Cai X, Lopez-Guisa JM, et al. (2001) PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60: 587-596.
50. Zhang G, Kim H, Cai X, Lopez-Guisa JM, Alpers CE, et al. (2003) Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 14: 1254-1271.
51. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, et al. (1996) Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49: 461-469.
52. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP (2000) Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis. Am J Kidney Dis 35: 726-738.
53. Hamano K, Iwano M, Akai Y, Sato H, Kubo A, et al. (2002) Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis 39: 695-705.
54. Chen SJ, Ning H, Ishida W, Sodin-Semrl S, Takagawa S, et al. (2006) The earlyimmediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J Biol Chem 281: 21183-21197.
55. Nakamura H, Isaka Y, Tsujie M, Rupprecht HD, Akagi Y, et al. (2002) Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Ther 9: 495-502.
56. Erkan E, De Leon M, Devarajan P (2001) Albumin overload induces apoptosis in LLC-PK(1) cells. Am J Physiol Renal Physiol 280: F1107-F1114.
57. Erkan E, Garcia CD, Patterson LT, Mishra J, Mitsnefes MM, et al. (2005) Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and Fas-dependent pathways. J Am Soc Nephrol 16: 398-407.
58. Stuart JR, Kawai H, Tsai KK, Chuang EY, Yuan ZM (2005) C-Abl regulates early growth response protein (EGR1) in response to oxidative stress. Oncogene 24: 8085-8092.
59. Yang-Yen HF (2006) Mcl-1: a highly regulated cell death and survival controller. J Biomed Sci 13: 201-204.
60. Sitailo LA, Tibudan SS, Denning MF (2006) The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis. J Biol Chem 281: 29703-29710.
61. Liu H, Eksarko P, Temkin V, Haines GK, III, Perlman H, et al. (2005) Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis. J Immunol 175: 8337-8345.
62. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO (2006) Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 25: 7555-7564.
63. Rudnicki M, Eder S, Perco P, Enrich J, Scheiber K, et al. (2007) Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int 71: 325-335.
64. Wang SN, LaPage J, Hirschberg R (2000) Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57: 1002-1014.
65. Iglesias J, Levine JS (2001) Albuminuria and renal injury-beware of proteins bearing gifts. Nephrol Dial Transplant 16: 215-218.
66. Kees-Folts D, Sadow JL, Schreiner GF (1994) Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45: 1697-1709.
67. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, et al. (2002) Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 62: 1628-1637.
68. Thomas ME, Harris KP, Walls J, Furness PN, Brunskill NJ (2002) Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol 283: F640-F647.
69. van Timmeren MM, Bakker SJ, Stegeman CA, Gans RO, van Goor H (2005) Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis. Nephrol Dial Transplant 20: 2349-2357.
70. Tarshish P, Tobin JN, Bernstein J, Edelmann CM, Jr. (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8: 769-776.
71. Drummond K, Mauer M (2002) The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51: 1580-1587.
72. Katz A, Caramori ML, Sisson-Ross S, Groppoli T, Basgen JM, et al. (2002) An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int 61: 2058-2066.
73. Woltman AM, de Fijter JW, Zuidwijk K, Vlug AG, Bajema IM, et al. (2007) Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 71: 1001-1008.
74. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, Hammerich L, Panzer U, et al. (2009) Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 119: 1286-1297.
75. Nikolic-Paterson DJ, Atkins RC (2001) The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 16 Suppl 5: 3-7.
76. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
77. Gentleman RDAH (2003) The Bioconductor FAQ. http://www.bioconductor.org/ (accessed 2008).
78. Irizarry R, Gautier L, Cope L (2003) An r package for analyses of affymetrix oligonucleotide arrays. In: Parmigiani G, Garrett ES, Irizarry RA, Zeger SL, eds. The Analysis of Gene Expression Data: Methods and Software. New York: Springer. pp 102-119.
79. Bolstad BM http://rmaexpress.bmbolstad.com/ (Accessed 2007).
80. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
81. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
82. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
83. Tritchler D, Fallah S, Beyene J (2005) A spectral clustering method for microarray data. Computational statistics & data analysis 49: 63-76.
84. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36.
85. Gentleman R (2007) Using GO for Statistical Analysis. www.bioconductor.org (accessed 2008).
86. Wettenhall J. Lab 7: Gene ontologies and gene sets in analysis of differential expression. http://www.amstat.org/meetings/jsm/2005/ (accessed 2007).
87. Tibshirani R (1996) Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B 58: 267-288.